Vitolo U et al. Brief chemoimmunotherapy R-FND with rituximab consolidation followed by randomization between rituximab maintenance vs observation as first line treatment in elderly patients with advanced follicular lymphoma (FL): Final results of a prospective randomized trial by Italian Lymphoma Foundation (FIL). Proc ASH 2011;Abstract 777. 

Dr Gregory is the Elodia Kehm Chair of Hematology, Professor of Medicine and Director of the Hematology Section at Rush University Medical Center in Chicago, Illinois.